Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Stapokibart With Endoscopic Sinus Surgery for CRSwNP
NCT07616609Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Stapokibart Treatment Group with Placebo Control Group (2 arms). Primary endpoint: Nasal Polyp Score. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
stapokibart
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07616609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616609.